Fibroblast Activation Protein Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fibroblast Activation Protein Inhibitor, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Unravelling Intestinal Fibrosis in Ulcerative Colitis [Phase 2, Phase 3]